scFv(14E1)-ETA
Alternative Names: anti-EGFR-monoclonal antibody-14E1Latest Information Update: 28 Aug 2002
At a glance
- Originator Bayer HealthCare Pharmaceuticals; Bayer Schering Pharma; Nonindustrial source
- Class Immunoglobulin fusion proteins; Monoclonal antibodies
- Mechanism of Action Epidermal growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 10 Mar 1999 Preclinical development for Cancer in Germany (Unknown route)